Successful use of intraventricular and intravenous rituximab therapy for refractory primary CNS lymphoma in a child

Leuk Lymphoma. 2007 Jun;48(6):1253-5. doi: 10.1080/10428190601142831.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage
  • Central Nervous System Neoplasms / drug therapy*
  • Drug Resistance, Neoplasm / drug effects
  • Humans
  • Injections, Intravenous
  • Injections, Intraventricular
  • Lymphoma, B-Cell / drug therapy*
  • Male
  • Remission Induction
  • Rituximab
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab